Pembrolizumab,Lenvatinib,Sunitinib
Merck,Pfizer,eisai
['kcsm,(-skcsm)', 'rcc,(-irccs),(-srcc),(-urcc)', 'lenva', 'pembro']
lenvatinib/pembrolizumab combo provides continued os, pfs benefit in advanced rcc #kcsm #esmo2022 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.